These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35643368)

  • 21. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.
    Sudrik C; Cloutier T; Pham P; Samra HS; Trout BL
    MAbs; 2017 Oct; 9(7):1155-1168. PubMed ID: 28758834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trehalose Limits Fragment Antibody Aggregation and Influences Charge Variant Formation in Spray-Dried Formulations at Elevated Temperatures.
    Rajagopal K; Chang D; Nayak P; Izadi S; Patapoff T; Zhang J; Kelley R; Sreedhara A
    Mol Pharm; 2019 Jan; 16(1):349-358. PubMed ID: 30525659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.
    Löbmann K; Laitinen R; Strachan C; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):882-8. PubMed ID: 23567485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
    Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
    Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
    Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF
    J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Method development and analysis of the water content of the maximally freeze concentrated solution suitable for protein lyophilisation.
    Seifert I; Bregolin A; Fissore D; Friess W
    Eur J Pharm Biopharm; 2020 Aug; 153():36-42. PubMed ID: 32526356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients.
    Robinson MJ; Matejtschuk P; Longstaff C; Dalby PA
    Mol Pharm; 2019 Feb; 16(2):744-755. PubMed ID: 30565948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility.
    Jena S; Krishna Kumar NS; Aksan A; Suryanarayanan R
    Int J Pharm; 2019 Oct; 569():118568. PubMed ID: 31352055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
    Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
    Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxylpropyl-β-cyclodextrin as Potential Excipient to Prevent Stress-Induced Aggregation in Liquid Protein Formulations.
    Stolzke T; Krieg F; Peng T; Zhang H; Häusler O; Brandenbusch C
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
    Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between calculated molecular descriptors of excipient amino acids and experimentally observed thermal stability of lysozyme.
    Meng-Lund H; Friis N; van de Weert M; Rantanen J; Poso A; Grohganz H; Jorgensen L
    Int J Pharm; 2017 May; 523(1):238-245. PubMed ID: 28336459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of formulation excipients with proteins in solution and in the dried state.
    Ohtake S; Kita Y; Arakawa T
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1053-73. PubMed ID: 21756953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.